In summary, we have provided insight into a novel signaling mechanism of TCTP regulation at the post-translational level in which the mTORC1/S6K signaling pathway negatively regulates a novel Akt/PLK1 axis and maintains TCTP at high levels in lung cancer cells. The gene discussed is PLK1; the disease is lung carcinoma.